Global Influenza Diagnostic Market
Healthcare Services

Global Influenza Diagnostic Market Size, Forecasts, And Opportunities

Learn about the global influenza diagnostic market through The Business Research Company, which provides information on influenza diagnostic market size, influenza diagnostic market drivers and restraints, influenza diagnostic market players, the COVID-19 impact on the influenza diagnostic market, and more.

Our annual holiday sale is here! Get your discounted market research reports today.

The global influenza diagnostic market is expected to grow from $1.31 billion in 2020 to $1.33 billion in 2021 at a compound annual growth rate (CAGR) of 1.5%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The influenza diagnostic market is expected to reach $1.74 billion in 2025 at a CAGR of 7%.

Increasing funding for research on influenza diagnostics is expected to drive innovation in influenza diagnostic, thus driving the market during the forecast period.

Request A Sample For The Global Influenza Diagnostic Market Report:

The influenza diagnostic market consists of sales of diagnostic tests used to diagnose influenza including viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue, and headache. The market consists of revenues generated by establishments conducting the diagnostics tests for influenza virus detection.

Global influenza diagnostic market segments include:

By Traditional Diagnostic Tests: Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Others

By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

By End User: Hospitals & Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Rapid influenza diagnostic tests (RIDTs) are increasingly being implemented in influenza diagnostics. RIDTs are immunoassays which can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens and display the result in a qualitative way (positive vs. negative). It can yield results in a clinically relevant time frame of less than approximately 15 minutes and diagnose patients, who are present with influenza-like illness, mainly if it is performed within the first four days of the onset of symptoms. The rising popularity of RIDT is due to the benefits such as simple to use and rapid diagnosis.

TBRC’s influenza diagnostic market report covers:

Major Market Players: F. Hoffmann-La Roche Ltd, Quidel Corporation, Thermo Fisher, Abbott Laboratories, Hologic, Becton, Dickinson and Company, DiaSorin S.p.A., Luminex Corporation, Meridian Bioscience, Inc., and GenMark Diagnostics

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The Influenza Diagnostic Global Market Report 2021: COVID-19 Implications And Growth to 2030 is one of a series of new reports from The Business Research Company that provides influenza diagnostic market overviews, analyzes and forecasts market size, share, influenza diagnostic market players, influenza diagnostic market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s influenza diagnostic market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here is a list of similar reports from The Business Research Company:

Microbiology Diagnostic Devices And Equipment Global Market Report 2021

Molecular Diagnostics Devices And Equipment Global Market Report 2021

Medical And Diagnostic Laboratory Services Global Market Report 2021

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293


Follow us on LinkedIn:

Follow us on Twitter:

Check out our Blog:

Check out our Global Market Model:

Leave a Reply

Your email address will not be published. Required fields are marked *